 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Lab Industry, Pathologists Still at Odds Over Fee Schedule for New Molecular Pathology CPT Codes
July 18, 2012
Lab Industry, Pathologists Still at Odds Over Fee Schedule for New Molecular Pathology CPT Codes
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Industry-Backed Bill Introduced in House as Frustration Grows over CMS Payment Process for MDx
October 3, 2012 / Pharmacogenomics Reporter - CMS Stance on Reimbursement of Multi-Analyte Algorithm Assays Raises Industry Concerns
September 19, 2012 / Pharmacogenomics Reporter - Posting 11 Percent Revenue Growth in FY2011, Myriad Focuses on Growing MDx Pipeline
August 10, 2011 / Pharmacogenomics Reporter - CMS Asks Labs to Submit New Molecular Dx Codes Alongside Stacked CPT Codes in 2012
December 21, 2011 / Pharmacogenomics Reporter - Palmetto Issuing 'Z-Codes' to Track Molecular Dx Utilization, Gather Data CPT Codes Can't Provide
November 16, 2011 / Pharmacogenomics Reporter